In many studies, it was proven to be effective in the treatment of neurodegenerative diseases since the increase of ADAM10 activity, which was the main α-secretase, which broke the APP, protected the brain from the accumulation of Aβ in AD [70,71]. This evidence concerns the gene ADAM10 and Alzheimer disease.